NovaBridge Biosciences American Depositary Shares
NBP
80 hedge funds and large institutions have $1.13B invested in NovaBridge Biosciences American Depositary Shares in 2021 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 30 increasing their positions, 15 reducing their positions, and 11 closing their positions.
2,007% more call options, than puts
Call options by funds: $295K | Put options by funds: $14K
136% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 11
125% more funds holding in top 10
Funds holding in top 10: 4 → 9 (+5)
100% more repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 15
84% more capital invested
Capital invested by funds: $616M → $1.13B (+$515M)
23% more funds holding
Funds holding: 65 → 80 (+15)
6.04% more ownership
Funds ownership: 8.06% → 14.09% (+6%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HA
HHLR Advisors
Grand Cayman,
Cayman Islands
|
+$278M |
| 2 |
WA
WFM Asia
Road Town, Tortola,
British Virgin Islands
|
+$56.3M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$37.4M |
| 4 |
GCM
Ghisallo Capital Management
Boston,
Massachusetts
|
+$22.8M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$22.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
-$31.9M |
| 2 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$14.2M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
-$10.2M |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$7.14M |
| 5 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$7.14M |
NBP Hedge Fund Activity: Q1 2021 in Review
80 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in NovaBridge Biosciences American Depositary Shares (NBP) for Q1 2021, worth a combined $1.13B — up 84% from $616M a quarter earlier.
Buyers outnumbered sellers: 26 funds opened new NBP positions and 11 closed out — a net gain of 15 holders — while 30 added to existing stakes and 15 trimmed.
The largest buyer was HHLR Advisors, adding an estimated $278M. The largest seller was OrbiMed, cutting an estimated $31.9M.
- 80 institutional investors held NovaBridge Biosciences American Depositary Shares (NBP) as of Q1 2021, up from 65 in Q4 2020.
- Funds reported $1.13B of NovaBridge Biosciences American Depositary Shares stock for Q1 2021, up 84% quarter-over-quarter.
- 26 funds opened new NovaBridge Biosciences American Depositary Shares positions in Q1 2021 and 11 closed out, a net change of +15 holders.
- The largest NovaBridge Biosciences American Depositary Shares buyer in Q1 2021 was HHLR Advisors, an estimated $278M added.
- The largest NovaBridge Biosciences American Depositary Shares seller in Q1 2021 was OrbiMed, an estimated $31.9M sold.
Based on aggregated 13F filings for Q1 2021.